Skip to content

Ligamentum Teres Tenodesis in Developmental Dysplasia of the Hip

The Role of Ligamentum Teres Tenodesis in the Management of Developmental Dysplasia of the Hip

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05432505
Enrollment
20
Registered
2022-06-27
Start date
2022-07-21
Completion date
2023-02-28
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopedic Disorder

Brief summary

The treatment of developmental dysplasia of the hip (DDH) remains challenging, yet recent advances have refined our understanding of how best to survey for the condition during infancy, minimize complications during early treatment, and refine the selection of patients who can best benefit from hip preservation surgery. The ideal continued target would be to prevent missed hip dislocations or dysplasia during the infant period, prevent avascular necrosis (AVN) during early treatment, and decrease the incidence of total hip arthroplasty in adulthood related to undertreated DDH, The goal of the treatment is to achieve a concentric reduction of the femoral head into the acetabulum.

Detailed description

it is an operative technique to secure the femoral head after reduction in cases of developmental dysplasia of the hip Operative technique: The surgery will be accomplished under a general anesthesia. An addition to the steps of the open reduction, the following were done: 1. Identification of ligamentum teres 2. ligamentum teres tenodesis

Interventions

Identification of ligamentum teres ligamentum teres tenodesis

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
9 Months to 60 Months

Inclusion criteria

* Patient with Developmental dysplasia of the hip (DDH) with : * Age: from 9 months -5 years old. * Virgin DDH. * Failed closed reduction in the management of DDH. * Failed open reduction through medial approach in the management of DDH

Exclusion criteria

* • Paralytic hip dislocation . * Post septic hip dislocation. * Traumatic hip dislocation . * Age : below 9 months or above 5 years. * Refusal to participate in this study.

Design outcomes

Primary

MeasureTime frameDescription
modified HHS6 monthsscore for function of the hip

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026